NCAM1 and COVID-19: One study reported that CD3-CD56+ NK cells frequency in the volunteers who recovered from mild COVID-19 (Mild CoV) presented a significant increase compared to the healthy control (HC) and individuals recovering from severe COVID-19 (Severe CoV) groups, indicating an essential role of NK cells in the process of SARS-CoV-2 control (36).